Long-Term Consequences of COVID-19 in Predominantly Immunonaive Patients: A Canadian Prospective Population-Based Study

Author:

Benoit-Piau Justine1,Tremblay Karine2ORCID,Piché Alain3,Dallaire Frédéric4ORCID,Bélanger Mathieu5,d’Entremont Marc-André67ORCID,Pasquier Jean-Charles8,Fortin Martin5ORCID,Bourque Catherine6,Lapointe Fanny2,Betala-Belinga Jean-François9,Petit Geneviève10,Jourdan Guillaume3,Bahous Renata11,Maya Camilo11,Benzina Amira11ORCID,Faiyaz Hossain Muhammad11,Peel Marie-Audrey11ORCID,Houle Olivier11,Auger Marie-Sandrine11,Rioux Antoine11,Farand Paul6

Affiliation:

1. Research Center of the Centre Hospitalier Universitaire de Sherbrooke (CHUS), University of Sherbrooke, Sherbrooke, QC J1H 5N4, Canada

2. Pharmacology and Physiology Department, Faculty of Medicine and Health Sciences, University of Sherbrooke, Sherbrooke, QC J1H 5N4, Canada

3. Department of Microbiology and Infectiology, University of Sherbrooke, Sherbrooke, QC J1H 5N4, Canada

4. Department of Pediatrics, University of Sherbrooke, Sherbrooke, QC J1H 5N4, Canada

5. Department of Family and Emergency Medicine, University of Sherbrooke, Sherbrooke, QC J1H 5N4, Canada

6. Division of Cardiology, Department of Medicine, Faculty of Medicine and Health Sciences, University of Sherbrooke, Sherbrooke, QC J1H 5N4, Canada

7. Population Health Research Institute, Hamilton, ON L8L 2X2, Canada

8. Department of Obstetrics and Gynecology, University of Sherbrooke, Sherbrooke, QC J1H 5N4, Canada

9. Direction of Saguenay-Lac-Saint-Jean Public Health Department, Saguenay, QC J1H 5N4, Canada

10. Department of Community Health Sciences, Faculty of Medicine and Health Sciences, University of Sherbrooke, Sherbrooke, QC J1H 5N4, Canada

11. Faculty of Medicine and Health Sciences, University of Sherbrooke, Sherbrooke, QC J1H 5N4, Canada

Abstract

Background: Lingering symptoms are frequently reported after acute SARS-CoV-2 infection, a condition known as post-COVID-19 condition (PCC). The duration and severity of PCC in immunologically naïve persons remain unclear. Furthermore, the long-term consequences of these chronic symptoms on work and mental health are poorly documented. Objective: To determine the outcome, the risk factors, and the impact on work and mental health associated with post-COVID-19 symptoms. Methods: This prospective population-based study assessed acute COVID-19 symptoms and their evolution for up to nine months following infection. Individuals aged 18 years and older with COVID-19 in three Canadian regions between 1 November 2020 and 31 May 2021 were recruited. Participants completed a questionnaire that was either administered by trained student investigators over the phone or self-administered online. Results: A total of 1349 participants with a mean age of 46.6 ± 16.0 years completed the questionnaire. Participants were mostly unvaccinated at the time of their COVID-19 episode (86.9%). Six hundred and twenty-two participants (48.0%) exhibited one symptom or more, at least three months post-COVID-19. Among participants with PCC, 23.0% to 37.8% experienced fatigue at the time of survey. Moreover, 6.1% expressed psychological distress. Risk factors for PCC and fatigue included female sex (OR = 1.996), higher number of symptoms (OR = 1.292), higher severity of episode (OR = 3.831), and having a mental health condition prior to the COVID-19 episode (OR = 5.155). Conclusions: In this multicenter cohort study, almost half (47%) of the participants reported persistent symptoms >3 months after acute infection. Baseline risk factors for PCC include female sex, number and severity of symptoms during acute infection, and a previous diagnosis of mental health disorder. Having PCC negatively impacted health-related quality of life and these patients were more likely to exhibit psychological distress, as well as fatigue.

Funder

Department of Medicine of Université de Sherbrooke

Publisher

MDPI AG

Subject

General Medicine

Reference32 articles.

1. Canada, A. (2022, June 17). de la Santé Publique du Maladie à Coronavirus (COVID-19): Mise à Jour Sur L’éclosion, Symptômes, Prévention, Voyage, Préparations. Available online: https://www.canada.ca/fr/sante-publique/services/maladies/maladie-coronavirus-covid-19.html.

2. Extrapulmonary manifestations of COVID-19;Gupta;Nat. Med.,2020

3. A rampage through the body;Wadman;Science,2020

4. COVID-19: From an acute to chronic disease? Potential long-term health consequences;Higgins;Crit. Rev. Clin. Lab. Sci.,2021

5. Long-Term Respiratory and Neurological Sequelae of COVID-19;Wang;Med. Sci. Monit.,2020

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3